Fluorescent Sensor Identifies Psychiatric Drugs - IDEX Health & ScienceIDEX Health & Science

    Disclaimer:

    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Fluorescent Sensor Identifies Psychiatric Drugs

    Article obtained from Photonics RSS Feed.

    A genetically encoded biosensor to detect hallucinogenic compounds could be used to aid in the discovery of treatments for mental illness, in neuroscience research, and to detect drugs of abuse. A team at the University of California, Davis (UC Davis) developed the sensor, called psychLight, which can be used to look for pharmaceutical potential without the side effect of hallucinations.

    Compounds related to psychedelic drugs such as LSD and DMT show promise in the treatment of depression, post-traumatic stress disorder, and substance abuse disorder. The drugs, called psychoplastogens, rapidly alter brain connections. These drugs can also cause hallucinations and require careful use and patient monitoring.

    Currently, the most…

    READ MORE
    Apr, 29 2021 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.